Changes in Amyloid-β and Tau in the Cerebrospinal Fluid of Transgenic Mice Overexpressing Amyloid Precursor Protein
- 17 July 2013
- journal article
- other
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 5 (194) , 194re2
Abstract
Changes in Aβ and Tau in the CSF of APP transgenic mice mirror the temporal sequence and magnitude of changes in these proteins in the CSF of Alzheimer’s disease patients.Keywords
This publication has 30 references indexed in Scilit:
- Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's DiseaseNew England Journal of Medicine, 2012
- Soluble Aβ Seeds Are Potent Inducers of Cerebral β-Amyloid DepositionThe Journal of Neuroscience, 2011
- Report of the task force on designing clinical trials in early (predementia) ADNeurology, 2011
- Peripherally Applied Aβ-Containing Inoculates Induce Cerebral β-AmyloidosisScience, 2010
- Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascadeThe Lancet Neurology, 2010
- Cerebrospinal fluid tau and ptau181 increase with cortical amyloid deposition in cognitively normal individuals: Implications for future clinical trials of Alzheimer's diseaseEMBO Molecular Medicine, 2009
- Prediction and longitudinal study of CSF biomarkers in mild cognitive impairmentNeurobiology of Aging, 2009
- Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjectsAnnals of Neurology, 2009
- Aβ42‐driven cerebral amyloidosis in transgenic mice reveals early and robust pathologyEMBO Reports, 2006
- Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine SystemNeuron, 2000